欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/2309/003
药品名称Carbidopa and Levodopa Accord 25/100 mg, prolonged release tablets
活性成分
    • carbidopa 25.0 mg
    • levodopa 100.0 mg
剂型Prolonged-release tablet
上市许可持有人Accord Healthcare BV Sage house, 319 Pinner Road HA1 4HF Middlesex United Kingdom Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Germany (DE)
      Carbidopa und Levodopa Accord 100/25 mg Retardtabletten
    • Denmark (DK)
      Levodopa/Carbidopa "Accord"
    • United Kingdom (GB)
    • Ireland (IE)
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
许可日期2016/09/08
最近更新日期2016/09/09
药物ATC编码
    • N04BA02 levodopa and decarboxylase inhibitor
申请类型
  • TypeLevel1：Line Extension
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase